Predict your next investment

HEALTHCARE | Medical Equipment & Supplies

See what CB Insights has to offer

Founded Year



Grant | Alive

Total Raised


About Sirius Genomics

Developer of diagnostics and pharmacogenetic tests for critical care medicine. The company develops DNA-based diagnostic (Dx) and pharmacogenetic (PGx) tests for critical care. The main product focus is concentrated on the development of Dx and PGx tests for sepsis, a systemic blood infection. [Keywords: personalized medicine]

Sirius Genomics Headquarter Location

1125 Howe Street, Suite 603

Vancouver, British Columbia, V6Z 2K8,



Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.